Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Celldex Therapeutics, Inc

CLDX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CLDX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CLDX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CLDX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CLDX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CLDX holdings by institutional investors

Quarterly net insider trading by CLDX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $90,000 Jul 20, 2026 Issue: Health Issues
  • $60,000 Apr 20, 2026 Issue: None
  • $60,000 Jan 20, 2026 Issue: Health Issues
  • $60,000 Oct 20, 2025 Issue: Health Issues
  • $60,000 Jul 21, 2025 Issue: Health Issues
  • $20,000 Apr 21, 2025 Issue: None

Former government officials who have lobbied for CLDX

5 former government officials from 4 congressional offices at 1 lobbying firm have lobbied for CLDX, most recently Jul 20, 2026.

  • Richard Hudson
    Molly Brimmer-Lolli House New Sr Cnsl, H Energy&Commrce Comm, Health Subcomm (2025-26); Cnsl H Energy&Commrce Comm, Health Subcomm (2023-25); Leg Dir, Rep. Hudson (2022-23); Sr Health Policy Advsr Rep. Hudson (2021-22); Leg Asst, Rep. Harris (2019-2021); Intrn, Rep. Harris (2014) Formerly with Richard Hudson · AKIN GUMP STRAUSS HAUER & FELD · Jul 20, 2026
  • Richard Burr
    Anna Abram Senate New Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06 Formerly with Richard Burr · AKIN GUMP STRAUSS HAUER & FELD · Mar 05, 2025
  • Kathy Castor
    Jocelyn Wiles House New Staffer, Rep. Kathy Castor (Jan. 07 - Feb. 11); Intern/Fellow, Rep. Barbara Lee (2006); Intern, Rep. Danny Davis (2004). Formerly with Kathy Castor · AKIN GUMP STRAUSS HAUER & FELD · Mar 05, 2025
  • Harry Reid
    Kandis Mcclure Senate New Intern for Sen. Harry Reid, Jan. - Apr. 2013 Formerly with Harry Reid · AKIN GUMP STRAUSS HAUER & FELD · Mar 05, 2025
  • Shawn Bishop Senate New Chief Health Advisor, US Sen. Finance Comm. (2/16/21-11/15/2024); Senior Advisor, US Sen. Finance Comm. (5/6/19 - 10/1/19); Professional Staff, US Sen. Finance Comm. (2/5/2005-10/1/2010). Formerly Finance Comm. · AKIN GUMP STRAUSS HAUER & FELD · Mar 05, 2025

CLDX Estimated quarterly lobbying spending

CLDX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CLDX Income Statement
CLDX Balance Sheet
CLDX Cash Flow
U.S. Patents

New CLDX patent grants

  • Patent Title: Agonistic antibodies that bind human cd40 and uses thereof May. 13, 2025
  • Patent Title: Treatment of eosinophil or mast cell related disorders May. 21, 2024
  • Patent Title: Anti-kit antibodies and uses thereof Feb. 06, 2024
  • Patent Title: Anti-met antibodies and methods of use thereof Jan. 30, 2024
  • Patent Title: Anti-kit antibodies and uses thereof Jan. 30, 2024
  • Patent Title: Anti-cd27 and anti-pd-l1 antibodies and bispecific constructs Oct. 04, 2022
  • Patent Title: Anti-cd27 and anti-pd-l1 antibodies and bispecific constructs May. 17, 2022
  • Patent Title: Antibodies that bind human cd27 and uses thereof Nov. 23, 2021
  • Patent Title: Anti-alk antibodies and methods for use thereof Aug. 17, 2021
  • Patent Title: Methods of inducing or enhancing an immune response comprising administering agonistic anti-cd40 antibodies Mar. 09, 2021
  • Patent Title: Nucleic acids encoding agonistic antibodies that bind cd40 Dec. 15, 2020
  • Patent Title: Methods of treating by administering anti-kit antibodies Oct. 06, 2020
  • Patent Title: Methods of treating by administering anti-kit antibodies Sep. 22, 2020
  • Patent Title: Treatment of eosinophil or mast cell related disorders Sep. 15, 2020
  • Patent Title: Anti-erbb antibodies and methods of use thereof Aug. 18, 2020
  • Patent Title: Treatment of eosinophil or mast cell related disorders Mar. 26, 2019
  • Patent Title: Polynucleotides encoding anti-kit antibodies Jan. 29, 2019
  • Patent Title: Methods of treating a kit-associated cancer by administering anti-kit antibodies Jan. 22, 2019
  • Patent Title: Treatment of chronic nephropathies using soluble complement receptor type i (scr1) May. 16, 2017
  • Patent Title: Method of improving transplant function using soluble complement receptor type i (scr1) May. 16, 2017
  • Patent Title: Antibodies that bind human dendritic and epithelial cell 205 (dec-205) Apr. 18, 2017
  • Patent Title: Polynucleotides encoding anti-kit antibodies Mar. 28, 2017
  • Patent Title: Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof Feb. 28, 2017
  • Patent Title: Treatment of chronic nephropathies using soluble complement receptor type i (scr1) Mar. 29, 2016
  • Patent Title: Antibody vaccine conjugates and uses therefor Feb. 16, 2016
  • Patent Title: Antibody vaccine conjugates and uses therefor Jan. 26, 2016
  • Patent Title: Antibodies that bind human cd27 and uses thereof Oct. 27, 2015
  • Patent Title: Monoclonal antibodies to dendritic cells Aug. 04, 2015
  • Patent Title: Method of detecting and treating tuberous sclerosis complex associated disorders Jun. 09, 2015
  • Patent Title: Antibodies directed to gpnmb and uses thereof Sep. 30, 2014
  • Patent Title: Treatment for age-related macular degeneration and other diseases of the eye Mar. 04, 2014
  • Patent Title: Antibodies that bind human dendritic and epithelial cell 205 (dec-205) Nov. 19, 2013
  • Patent Title: Antibodies that bind human dendritic and epithelial cell 205 (dec-205) Jan. 29, 2013
  • Patent Title: Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp) Nov. 27, 2012
  • Patent Title: Antibodies that bind human dendritic and epithelial cell 205 (dec-205) Aug. 07, 2012
  • Patent Title: Method for enhancing t cell reactivity toward tumour antigens Mar. 16, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to CLDX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
CLDX News

Recent insights relating to CLDX

CNBC Recommendations

Recent picks made for CLDX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CLDX

CLDX Analyst Ratings

CLDX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CLDX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CLDX stock a Buy, Sell, or Hold?

  • What is the price target for $CLDX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CLDX Top Shareholders
Shareholder
Shares Held
CLDX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CLDX stock?

  • Who owns the most shares of $CLDX stock?

  • What funds own $CLDX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CLDX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CLDX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CLDX

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

  • Address Hampton, NJ
  • Market Cap 2.4 billion
  • Employees 198
  • Industrial Classification In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc (CLDX) Historical Stock Prices

Celldex Therapeutics, Inc (CLDX) closed at $31.10 on September 25, 2026. Over the past year its adjusted close ranged from $22.58 to $44.87. Daily prices go back to January 2, 2014, 3,202 trading days in all.

  • 1 month-23.34%
  • 3 months-11.80%
  • Year to date+14.51%
  • 1 year+23.17%
  • 3 years+17.31%
  • 5 years-43.67%
  • Max-91.57%
See every congressional and insider trade on the CLDX price chart

Quiver Premium charts CLDX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 31.48 31.70 30.65 31.10 31.10 2,023,927
Sep 24, 2026 31.48 31.66 30.59 31.48 31.48 2,297,688
Sep 23, 2026 33.54 33.59 30.41 31.12 31.12 4,235,974
Sep 22, 2026 36.60 38.39 30.39 33.51 33.51 12,888,897
Sep 21, 2026 41.62 41.62 37.48 37.89 37.89 549,512
Sep 18, 2026 38.87 38.87 37.53 38.24 38.24 2,081,882
Sep 17, 2026 39.47 40.66 38.92 38.98 38.98 1,278,921
Sep 16, 2026 38.59 39.21 38.25 38.71 38.71 1,001,441
Sep 15, 2026 39.00 39.19 37.74 38.51 38.51 686,390
Sep 14, 2026 37.40 39.42 37.27 39.18 39.18 1,000,173
Sep 11, 2026 38.39 38.59 36.84 36.90 36.90 1,033,541
Sep 10, 2026 38.78 38.86 37.75 38.10 38.10 949,012
Sep 9, 2026 38.95 40.03 38.67 38.78 38.78 588,415
Sep 8, 2026 38.78 39.87 38.50 39.12 39.12 834,305
Sep 4, 2026 38.96 39.81 38.90 39.68 39.68 414,532
Sep 3, 2026 39.50 39.88 38.95 39.37 39.37 417,999
Sep 2, 2026 39.43 40.55 39.01 39.48 39.48 476,586
Sep 1, 2026 39.13 39.90 38.94 39.24 39.24 542,483
Aug 31, 2026 38.86 39.84 38.74 39.63 39.63 696,907
Aug 28, 2026 40.33 40.57 39.04 39.12 39.12 424,938
Aug 27, 2026 40.44 40.99 40.02 40.46 40.46 450,009
Aug 26, 2026 41.18 42.12 40.06 40.57 40.57 540,668
Aug 25, 2026 41.02 41.92 40.63 41.22 41.22 550,919
Aug 24, 2026 40.16 40.98 39.53 40.57 40.57 416,889
Aug 21, 2026 40.38 41.24 40.12 40.38 40.38 837,685
Aug 20, 2026 41.40 42.00 39.45 39.94 39.94 1,002,530
Aug 19, 2026 42.10 43.20 41.33 41.70 41.70 1,392,384
Aug 18, 2026 41.29 42.36 41.03 41.79 41.79 998,961
Aug 17, 2026 41.54 42.80 41.07 41.92 41.92 629,804
Aug 14, 2026 42.23 42.34 40.88 41.95 41.95 849,364
Aug 13, 2026 45.13 45.13 42.56 42.61 42.61 670,929
Aug 12, 2026 44.40 45.14 43.80 44.87 44.87 1,594,598
Aug 11, 2026 42.81 44.59 42.46 44.33 44.33 767,368
Aug 10, 2026 41.71 43.21 41.41 42.97 42.97 727,630
Aug 7, 2026 41.87 42.92 41.29 41.71 41.71 808,912
Aug 6, 2026 41.12 41.74 40.84 41.56 41.56 799,089
Aug 5, 2026 39.36 41.15 38.86 41.06 41.06 788,876
Aug 4, 2026 37.69 39.34 37.54 39.05 39.05 1,027,484
Aug 3, 2026 38.09 38.59 37.05 37.69 37.69 1,635,247
Jul 31, 2026 38.50 38.65 37.15 38.06 38.06 875,735
Jul 30, 2026 37.26 38.59 37.23 38.48 38.48 743,234
Jul 29, 2026 35.58 37.76 35.58 37.51 37.51 1,572,692
Jul 28, 2026 35.93 36.05 35.00 35.58 35.58 565,896
Jul 27, 2026 35.68 36.40 35.12 35.65 35.65 1,040,865
Jul 24, 2026 35.76 35.76 34.73 35.28 35.28 639,231
Jul 23, 2026 34.25 35.75 33.97 35.42 35.42 856,468
Jul 22, 2026 33.83 36.09 33.37 34.77 34.77 1,928,820
Jul 21, 2026 35.58 36.00 34.56 35.66 35.66 1,392,017
Jul 20, 2026 36.05 36.65 35.29 35.42 35.42 527,637
Jul 17, 2026 34.71 36.04 34.37 35.35 35.35 1,149,060
Jul 16, 2026 37.49 37.94 34.97 35.40 35.40 954,885
Jul 15, 2026 38.13 38.69 37.51 38.31 38.31 534,208
Jul 14, 2026 38.70 39.22 38.08 38.17 38.17 702,069
Jul 13, 2026 38.61 38.66 37.52 38.53 38.53 660,189
Jul 10, 2026 38.90 39.19 37.81 39.11 39.11 694,010
Jul 9, 2026 39.30 39.59 38.55 38.98 38.98 612,506
Jul 8, 2026 39.48 40.19 38.68 38.96 38.96 1,618,302
Jul 7, 2026 38.13 40.30 37.30 39.93 39.93 1,701,313
Jul 6, 2026 38.20 38.50 37.26 37.95 37.95 470,283
Jul 2, 2026 36.95 38.42 36.17 38.37 38.37 876,831
Jul 1, 2026 37.15 37.64 36.57 36.78 36.78 679,564
Jun 30, 2026 37.42 39.16 36.96 37.21 37.21 2,473,018
Jun 29, 2026 35.32 37.54 34.66 37.44 37.44 1,579,642
Jun 26, 2026 34.06 35.47 33.77 35.26 35.26 4,785,830
Jun 25, 2026 33.71 35.39 33.70 34.09 34.09 1,143,621
Jun 24, 2026 32.95 34.15 32.62 33.78 33.78 1,227,357
Jun 23, 2026 32.87 33.72 32.57 32.98 32.98 669,864
Jun 22, 2026 32.90 33.46 32.26 33.41 33.41 1,957,840
Jun 18, 2026 33.69 34.14 32.35 32.43 32.43 2,378,576
Jun 17, 2026 32.58 33.55 32.29 32.93 32.93 991,670
Jun 16, 2026 32.20 32.45 31.41 32.32 32.32 999,434
Jun 15, 2026 31.29 32.21 31.05 32.12 32.12 1,007,164
Jun 12, 2026 29.94 31.41 29.94 31.27 31.27 599,806
Jun 11, 2026 29.41 30.21 29.33 29.96 29.96 982,699
Jun 10, 2026 29.92 30.34 29.29 29.35 29.35 490,422
Jun 9, 2026 29.03 29.73 28.54 29.60 29.60 616,942
Jun 8, 2026 28.87 29.00 28.38 28.56 28.56 629,704
Jun 5, 2026 29.83 30.05 28.46 28.62 28.62 1,273,657
Jun 4, 2026 30.10 30.62 29.82 29.93 29.93 592,049
Jun 3, 2026 28.90 29.86 28.70 29.77 29.77 876,153
Jun 2, 2026 29.73 29.88 28.82 28.90 28.90 918,548
Jun 1, 2026 31.02 31.12 29.61 30.14 30.14 1,020,660
May 29, 2026 31.79 32.00 31.09 31.43 31.43 494,672
May 28, 2026 31.30 32.30 30.91 31.70 31.70 727,137
May 27, 2026 31.01 32.24 30.89 31.65 31.65 503,024
May 26, 2026 30.84 31.12 30.40 30.85 30.85 726,197
May 22, 2026 30.66 31.22 30.65 30.73 30.73 582,927
May 21, 2026 30.75 31.08 30.12 30.58 30.58 904,362
May 20, 2026 30.40 31.18 30.35 30.90 30.90 738,856
May 19, 2026 30.08 30.37 29.27 30.15 30.15 566,904
May 18, 2026 31.45 31.98 29.70 30.22 30.22 826,076
May 15, 2026 32.07 32.38 31.13 31.34 31.34 682,146
May 14, 2026 32.70 32.83 31.60 32.45 32.45 576,700
May 13, 2026 32.25 33.08 31.91 32.51 32.51 1,157,169
May 12, 2026 32.45 32.49 31.73 32.00 32.00 773,793
May 11, 2026 33.98 34.78 31.76 32.28 32.28 960,368
May 8, 2026 34.94 34.94 32.62 33.97 33.97 794,141
May 7, 2026 34.25 34.25 32.58 33.32 33.32 886,620
May 6, 2026 33.91 34.54 33.33 34.39 34.39 534,788
May 5, 2026 33.13 34.20 32.43 33.86 33.86 725,602
May 4, 2026 32.17 33.01 32.17 32.77 32.77 481,067
May 1, 2026 32.90 33.86 32.17 32.31 32.31 411,462
Apr 30, 2026 32.70 33.32 32.29 32.88 32.88 647,950
Apr 29, 2026 32.73 33.04 31.65 32.14 32.14 602,775
Apr 28, 2026 33.96 34.61 33.19 33.23 33.23 770,410
Apr 27, 2026 33.15 34.65 33.15 33.66 33.66 851,876
Apr 24, 2026 33.80 33.80 32.88 33.29 33.29 597,141
Apr 23, 2026 34.51 34.96 33.19 33.55 33.55 728,832
Apr 22, 2026 34.57 34.74 33.84 34.21 34.21 787,270
Apr 21, 2026 34.39 34.39 33.64 34.25 34.25 797,903
Apr 20, 2026 35.79 35.79 34.34 34.38 34.38 943,377
Apr 17, 2026 34.55 35.29 34.32 34.55 34.55 1,481,146
Apr 16, 2026 33.82 33.97 33.28 33.86 33.86 853,186
Apr 15, 2026 33.58 34.26 33.49 33.87 33.87 971,668
Apr 14, 2026 32.23 33.72 31.96 33.33 33.33 844,339
Apr 13, 2026 32.31 32.83 32.11 32.59 32.59 691,150
Apr 10, 2026 33.60 33.73 32.08 32.24 32.24 696,127
Apr 9, 2026 32.45 33.86 32.23 33.62 33.62 815,378
Apr 8, 2026 31.97 32.59 31.04 32.41 32.41 1,776,803
Apr 7, 2026 30.96 31.62 30.52 31.35 31.35 1,878,450
Apr 6, 2026 31.77 32.32 30.88 31.37 31.37 1,918,680
Apr 2, 2026 29.31 31.39 28.41 31.06 31.06 5,167,187
Apr 1, 2026 31.94 32.61 31.14 31.26 31.26 432,960
Mar 31, 2026 30.48 32.42 30.46 31.72 31.72 1,369,564
Mar 30, 2026 30.24 30.67 29.30 29.48 29.48 650,120
Mar 27, 2026 31.29 31.75 30.00 30.30 30.30 904,825
Mar 26, 2026 31.17 32.66 31.17 31.75 31.75 762,701
Mar 25, 2026 31.77 32.44 31.39 31.68 31.68 657,003
Mar 24, 2026 31.40 31.97 30.50 31.19 31.19 936,272
Mar 23, 2026 32.80 34.52 31.73 31.80 31.80 1,496,616
Mar 20, 2026 30.26 31.85 29.95 30.90 30.90 3,242,637
Mar 19, 2026 28.18 30.45 27.92 30.03 30.03 1,043,838
Mar 18, 2026 29.38 29.72 28.40 28.54 28.54 733,703
Mar 17, 2026 30.18 30.30 29.55 29.64 29.64 417,748
Mar 16, 2026 29.90 30.76 29.71 30.19 30.19 776,810
Mar 13, 2026 30.29 30.93 29.37 29.51 29.51 510,034
Mar 12, 2026 30.75 30.75 29.34 29.88 29.88 685,856
Mar 11, 2026 31.07 31.68 30.55 31.23 31.23 811,910
Mar 10, 2026 30.87 31.99 30.56 31.15 31.15 1,079,263
Mar 9, 2026 29.21 31.85 29.21 30.73 30.73 1,677,758
Mar 6, 2026 28.81 29.83 28.62 29.43 29.43 673,265
Mar 5, 2026 29.05 29.59 28.58 29.36 29.36 788,487
Mar 4, 2026 29.06 30.14 28.95 29.54 29.54 875,403
Mar 3, 2026 28.72 30.04 28.72 28.94 28.94 1,250,969
Mar 2, 2026 29.94 30.69 29.62 30.00 30.00 1,066,086
Feb 27, 2026 30.15 30.45 29.43 30.09 30.09 1,378,953
Feb 26, 2026 30.05 31.31 29.84 30.64 30.64 1,673,209
Feb 25, 2026 25.55 31.00 25.40 30.82 30.82 3,796,853
Feb 24, 2026 24.53 25.11 24.18 24.84 24.84 830,140
Feb 23, 2026 23.65 24.90 23.55 24.32 24.32 1,088,248
Feb 20, 2026 23.34 23.79 22.60 23.02 23.02 448,078
Feb 19, 2026 22.87 23.60 22.63 23.54 23.54 582,257
Feb 18, 2026 22.93 23.54 22.91 23.00 23.00 614,164
Feb 17, 2026 22.94 23.45 22.45 22.94 22.94 766,663
Feb 13, 2026 23.66 24.29 22.50 23.00 23.00 1,187,040
Feb 12, 2026 24.57 24.78 23.09 23.57 23.57 413,744
Feb 11, 2026 24.72 25.02 23.62 24.60 24.60 384,473
Feb 10, 2026 24.69 25.24 24.46 24.63 24.63 362,860
Feb 9, 2026 23.74 24.88 23.12 24.81 24.81 454,029
Feb 6, 2026 23.15 23.98 22.33 23.76 23.76 818,649
Feb 5, 2026 24.04 24.34 22.55 22.58 22.58 1,218,268
Feb 4, 2026 25.32 25.34 24.02 24.27 24.27 598,034
Feb 3, 2026 24.72 25.60 24.68 25.17 25.17 818,243
Feb 2, 2026 24.60 25.14 24.37 24.66 24.66 736,377
Jan 30, 2026 24.39 24.99 23.95 24.60 24.60 568,285
Jan 29, 2026 24.73 25.10 24.37 24.69 24.69 401,156
Jan 28, 2026 26.21 26.21 24.58 24.77 24.77 359,603
Jan 27, 2026 26.56 26.86 25.94 26.23 26.23 346,651
Jan 26, 2026 25.57 26.75 25.40 26.57 26.57 898,798
Jan 23, 2026 26.56 26.74 25.71 25.92 25.92 361,236
Jan 22, 2026 26.03 26.96 25.70 26.85 26.85 323,004
Jan 21, 2026 25.40 26.21 25.32 26.17 26.17 399,006
Jan 20, 2026 25.44 25.61 25.00 25.14 25.14 464,371
Jan 16, 2026 25.78 26.14 25.57 25.65 25.65 675,539
Jan 15, 2026 26.24 26.45 25.27 25.69 25.69 730,545
Jan 14, 2026 25.95 26.98 25.79 26.34 26.34 1,261,921
Jan 13, 2026 25.68 26.50 25.14 25.93 25.93 855,749
Jan 12, 2026 27.20 27.20 25.26 25.67 25.67 1,060,660
Jan 9, 2026 27.59 28.00 27.00 27.38 27.38 544,786
Jan 8, 2026 27.27 27.96 26.99 27.35 27.35 777,492
Jan 7, 2026 26.52 28.27 26.37 27.76 27.76 593,044
Jan 6, 2026 25.35 26.37 25.15 26.28 26.28 815,569
Jan 5, 2026 27.04 27.30 25.50 25.60 25.60 783,537
Jan 2, 2026 26.91 27.44 26.62 27.01 27.01 1,005,162
Dec 31, 2025 26.34 27.65 25.90 27.16 27.16 722,719
Dec 30, 2025 25.83 26.50 25.54 26.43 26.43 1,167,841
Dec 29, 2025 26.33 26.60 25.51 26.03 26.03 491,410
Dec 26, 2025 26.57 26.59 26.05 26.40 26.40 356,294
Dec 24, 2025 26.58 26.95 26.39 26.83 26.83 221,201
Dec 23, 2025 27.13 27.43 26.22 26.58 26.58 463,673
Dec 22, 2025 25.47 27.92 25.39 27.27 27.27 738,397
Dec 19, 2025 25.42 26.04 25.09 25.60 25.60 1,565,703
Dec 18, 2025 25.99 26.16 24.97 25.29 25.29 476,218
Dec 17, 2025 26.59 26.95 25.70 25.77 25.77 678,608
Dec 16, 2025 26.95 27.16 26.56 26.68 26.68 592,892
Dec 15, 2025 27.90 27.90 26.82 27.09 27.09 864,323
Dec 12, 2025 28.02 28.14 27.29 27.51 27.51 658,746
Dec 11, 2025 28.23 28.79 27.86 27.94 27.94 669,856
Dec 10, 2025 28.10 28.72 27.50 28.19 28.19 895,951
Dec 9, 2025 29.71 29.91 27.78 28.09 28.09 1,561,576
Dec 8, 2025 29.85 30.50 29.11 29.80 29.80 1,092,687
Dec 5, 2025 29.50 29.83 28.82 29.45 29.45 1,067,669
Dec 4, 2025 27.68 29.71 27.68 29.60 29.60 741,926
Dec 3, 2025 26.82 28.49 26.68 27.81 27.81 804,537
Dec 2, 2025 26.34 27.75 25.92 26.67 26.67 831,268
Dec 1, 2025 26.60 26.73 25.69 25.92 25.92 464,783
Nov 28, 2025 26.82 27.05 26.61 27.02 27.02 292,050
Nov 26, 2025 26.27 26.82 26.02 26.79 26.79 462,131
Nov 25, 2025 26.36 26.59 25.71 26.44 26.44 408,540
Nov 24, 2025 26.08 26.63 25.05 26.32 26.32 755,234
Nov 21, 2025 24.93 26.09 24.79 25.92 25.92 607,669
Nov 20, 2025 24.93 26.10 24.73 25.07 25.07 662,032
Nov 19, 2025 25.35 25.99 24.53 24.92 24.92 893,460
Nov 18, 2025 25.58 25.99 24.92 25.58 25.58 606,010
Nov 17, 2025 25.46 26.50 25.40 26.00 26.00 1,285,704
Nov 14, 2025 23.47 25.62 23.47 25.55 25.55 962,600
Nov 13, 2025 23.95 24.64 23.62 23.72 23.72 753,191
Nov 12, 2025 24.22 25.03 23.67 24.25 24.25 807,608
Nov 11, 2025 22.26 24.77 22.10 24.37 24.37 1,507,241
Nov 10, 2025 23.28 23.55 22.30 22.67 22.67 1,384,048
Nov 7, 2025 23.26 23.26 22.50 22.90 22.90 771,918
Nov 6, 2025 23.49 23.77 23.01 23.26 23.26 822,401
Nov 5, 2025 23.86 24.14 23.29 23.73 23.73 890,688
Nov 4, 2025 24.00 24.75 23.65 23.85 23.85 1,300,584
Nov 3, 2025 26.46 26.80 24.40 24.75 24.75 1,344,053
Oct 31, 2025 26.00 26.84 25.69 26.73 26.73 1,176,169
Oct 30, 2025 25.92 26.64 25.90 26.00 26.00 850,790
Oct 29, 2025 26.85 27.00 25.70 25.99 25.99 636,937
Oct 28, 2025 27.24 27.65 26.80 27.06 27.06 507,114
Oct 27, 2025 26.82 27.85 26.80 27.37 27.37 624,006
Oct 24, 2025 26.62 26.77 26.18 26.72 26.72 461,862
Oct 23, 2025 26.80 26.90 25.97 26.26 26.26 822,124
Oct 22, 2025 27.91 28.20 26.55 26.72 26.72 639,699
Oct 21, 2025 28.03 28.59 27.44 27.91 27.91 902,584
Oct 20, 2025 27.58 27.80 26.60 27.67 27.67 633,200
Oct 17, 2025 26.35 27.01 26.03 26.83 26.83 704,642
Oct 16, 2025 27.53 27.89 26.17 26.55 26.55 773,773
Oct 15, 2025 26.21 27.73 26.10 27.34 27.34 978,817
Oct 14, 2025 26.81 27.44 26.45 26.47 26.47 964,084
Oct 13, 2025 24.87 27.40 24.50 27.13 27.13 1,100,938
Oct 10, 2025 27.62 27.73 26.31 26.77 26.77 1,208,522
Oct 9, 2025 27.20 27.98 26.96 27.54 27.54 786,542
Oct 8, 2025 26.40 27.83 26.16 27.24 27.24 1,066,887
Oct 7, 2025 26.45 26.45 25.81 26.22 26.22 643,446
Oct 6, 2025 26.50 26.90 26.05 26.38 26.38 927,305
Oct 3, 2025 25.99 26.51 25.93 26.41 26.41 967,490
Oct 2, 2025 25.38 25.87 24.49 25.85 25.85 907,351
Oct 1, 2025 25.88 26.06 25.15 25.29 25.29 1,121,430
Sep 30, 2025 25.96 26.20 25.43 25.87 25.87 1,168,521
Sep 29, 2025 26.14 26.46 25.76 26.19 26.19 739,805
Sep 26, 2025 25.68 26.37 25.24 26.14 26.14 963,919
Sep 25, 2025 25.57 25.60 24.79 25.25 25.25 1,058,159

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Celldex Therapeutics, Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CLDX, per a recent SEC DEF 14A filing. We estimate that the median employee at Celldex Therapeutics, Inc. is paid $236,393.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation